Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Fanconi Anemia 1Carcinoma, Ovarian Epithelial 1

Interventions

Psychiatric Rehabilitation 3Immunoenzyme Techniques 3Flow Cytometry 3Polymerase Chain Reaction 2Microarray Analysis 2Watchful Waiting 1Reverse Transcriptase Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Influenza Vaccines 1In Situ Hybridization, Fluorescence 1Immunosuppression Therapy 1Immunologic Techniques 1Gene Expression Profiling 1Fentanyl 1Electrophoresis, Polyacrylamide Gel 1Drug Therapy 1Data Collection 1Dapsone 1Cytogenetic Analysis 1Chromatography, High Pressure Liquid 1Chromatography 1Blotting, Western 1Blood Specimen Collection 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Myelodysplastic-Myeloproliferative Diseases × Chromatography × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡